JPS57192315A - Obese patient long-term weight reduction employing femoxetine - Google Patents

Obese patient long-term weight reduction employing femoxetine

Info

Publication number
JPS57192315A
JPS57192315A JP57075588A JP7558882A JPS57192315A JP S57192315 A JPS57192315 A JP S57192315A JP 57075588 A JP57075588 A JP 57075588A JP 7558882 A JP7558882 A JP 7558882A JP S57192315 A JPS57192315 A JP S57192315A
Authority
JP
Japan
Prior art keywords
femoxetine
weight reduction
obese patient
term weight
patient long
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57075588A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6121602B2 (https=
Inventor
Buusu Ratsusen Ierugen
Aa Kurisutensen Ierugen
Kaa Sukurumusaageru Birute
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia Animal Health Inc
Original Assignee
Ferrosan AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan AB filed Critical Ferrosan AB
Publication of JPS57192315A publication Critical patent/JPS57192315A/ja
Publication of JPS6121602B2 publication Critical patent/JPS6121602B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
JP57075588A 1981-05-07 1982-05-07 Obese patient long-term weight reduction employing femoxetine Granted JPS57192315A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/261,479 US4442113A (en) 1981-05-07 1981-05-07 Long-term weight reduction of obese patients using femoxetine

Publications (2)

Publication Number Publication Date
JPS57192315A true JPS57192315A (en) 1982-11-26
JPS6121602B2 JPS6121602B2 (https=) 1986-05-28

Family

ID=22993481

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57075588A Granted JPS57192315A (en) 1981-05-07 1982-05-07 Obese patient long-term weight reduction employing femoxetine

Country Status (3)

Country Link
US (1) US4442113A (https=)
JP (1) JPS57192315A (https=)
DE (1) DE3213091A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6069065A (ja) * 1983-03-07 1985-04-19 ノボ　ノルディスク、アクティーゼルスカブ ラセミ化トランス―３―［（４―メトキシフェノキシ）―メチル］―１―メチル―４―フェニルピペリジンの光学的分割方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
US4895845A (en) * 1986-09-15 1990-01-23 Seed John C Method of assisting weight loss
US5635535A (en) * 1996-04-05 1997-06-03 Wagstaff; Robert K. Method for increasing blood glucose levels
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
US6852342B2 (en) * 2002-03-26 2005-02-08 Avoca, Inc. Compounds for altering food intake in humans
US20060084636A1 (en) * 2004-10-18 2006-04-20 Maria Alemany Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same
US20060084637A1 (en) * 2004-10-18 2006-04-20 Maria Alemany Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
US20100247453A1 (en) * 2006-07-12 2010-09-30 Thomas L. Jones Composition and method of treating a sore throat
US7754234B2 (en) * 2006-07-12 2010-07-13 Jones Thomas L Composition and method of treating a sore throat

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6069065A (ja) * 1983-03-07 1985-04-19 ノボ　ノルディスク、アクティーゼルスカブ ラセミ化トランス―３―［（４―メトキシフェノキシ）―メチル］―１―メチル―４―フェニルピペリジンの光学的分割方法

Also Published As

Publication number Publication date
US4442113A (en) 1984-04-10
DE3213091A1 (de) 1982-11-25
JPS6121602B2 (https=) 1986-05-28

Similar Documents

Publication Publication Date Title
DE3264395D1 (en) Ileostomy valve
JPS57175358A (en) Wheelchair
GB8508107D0 (en) Ostomy appliance
JPS57130682A (en) Hook structure
GB2102757B (en) Counterbalancing loads
GB8300069D0 (en) Heart valve
DE3271399D1 (en) Lifting chair
GB8529069D0 (en) Orthosis
DE3563903D1 (en) Ostomy appliance
GB8420127D0 (en) Ostomy appliance
JPS57192315A (en) Obese patient long-term weight reduction employing femoxetine
DE3273455D1 (en) Fire-resistant support for the human body
DE3279857D1 (en) Analog-to-digital converter
GB2111000B (en) Wheelchair attachment
GB2156211B (en) Bedpan
JPS57185819A (en) Electromotive cooker
GB2103560B (en) Lowering device
GB2100122B (en) Hospital bed
DE3269705D1 (en) Analog-to-digital converter
GB2190841B (en) Ostomy appliance
GB2105185B (en) Beds
JPS57185818A (en) Electromotive cooker
JPS57160442A (en) Stethoscope
JPS57148935A (en) Stethoscope
EP0067544A3 (en) Analog-to-digital converter